Cite
MLA Citation
A. H. Gershlick et al.. “Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial..” Heart, vol. 71, no. 1, 1994, pp. 7–15. http://access.bl.uk/ark:/81055/vdc_100144732722.0x000044